Bevacizumab.

F. Kazazi-Hyseni; J.H. Beijnen; J.H.M. Schellens

Bevacizumab.

F. Kazazi-Hyseni, J.H. Beijnen, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	819-825
Number of pages	7
Journal	Oncologist
Volume	15
Issue number	8
Publication status	Published - 2010

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{4ea97dca25d445c88aaffdc1da730aef,

title = "Bevacizumab.",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "F. Kazazi-Hyseni and J.H. Beijnen and J.H.M. Schellens",

year = "2010",

language = "Undefined/Unknown",

volume = "15",

pages = "819--825",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Bevacizumab.

AU - Kazazi-Hyseni, F.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2010

Y1 - 2010

KW - Epidemiology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Ziekenhuisstructuur en organisatie van de gezondheidszorg

KW - Public Health

M3 - Article

SN - 1083-7159

VL - 15

SP - 819

EP - 825

JO - Oncologist

JF - Oncologist

IS - 8

ER -